Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

QUOTED. Jan. 11, 2019. Ben Newton.

Executive Summary

GE Healthcare is collaborating with Vanderbilt University Medical Center to develop AI-powered diagnostic tools for cancer care. Ben Newton, GE Healthcare's chief digital officer, explained that GE hopes the partnership will help GE become a leader in precision medicine by developing algorithms and artificial intelligence systems that can predict adverse events in cancer patients.

"For predictive analytics we will partner with Vanderbilt on their database of cancer patients so electronic records, imaging records, genomic profiling, biopsy data, demographics. We will then develop algorithms and apply AI that can predict adverse events, in first instance, to immunotherapies and, in the second instance, which patients are more likely to benefit from immunotherapies, and then we'll look further beyond that for other opportunities." -Ben Newton, chief digital officer, GE Healthcare

Click here for a free trial of Medtech Insight
 

 

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT124477

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel